SCYNEXIS share price logo

SCYNEXIS

NASDAQ: SCYX

$5.09

-0.28

(-5.21%)

as on

SCYNEXIS Stock Performance

as on October 3, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.10
    $5.51
    downward going graph

    -0.20%

    Downside

    8.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.53
    $9.12
    downward going graph

    30.65%

    Downside

    79.17%

    Upside

    downward going graph

SCYNEXIS share price movements today

Previous Close
$5.37
Open
$5.40
Volume
264.0K
Market Cap
$49.2M
Day's Low - High
$5.10 - $5.51
52 Week Low - High
$3.53 - $9.12

SCYNEXIS Historical Returns

1 Month Return
+ 2.87 %
3 Month Return
+ 21.22 %
1 Year Return
-15.7 %
3 Year Return
-69.21 %
5 Year Return
-87.02 %

SCYNEXIS Stock Fundamentals & Key Indicators

Check SCYNEXIS market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$49.2M

EPS (TTM)

-1.84

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.68

Industry PE ratio

-8.55

PEG Ratio

0.01

EBITDA

-10.2M

Revenue (TTM)

19.2M

Profit Margin

100.00%

Return On Equity TTM

-21.10%

SCYNEXIS vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SCYNEXIS with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SCYNEXIS image
SCYNEXIS
Buy$49.2M-87.02%-2.68100.00%0.00%
United Therapeutics image
United Therapeutics
Buy$24.5B207.36%17.9386.14%0.00%
Viatris image
Viatris
Buy$20.8B30.29%-50.2334.83%2.65%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
Buy$39.3BNA18.6165.57%1.38%
Zoetis image
Zoetis
Buy$29.0B-64.78%11.4970.87%2.99%
See all

Stock Returns calculator for SCYNEXIS Stock including INR - Dollar returns

The SCYNEXIS stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

SCYNEXIS investment value today

Current value as on today

₹86,727

Returns

-₹13,273

(-13.27%)

Returns from SCYNEXIS Stock

-₹20,099 (-20.1%)

Dollar Impact

₹6,827 (+6.83%)

Analyst Recommendation on SCYNEXIS Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for SCYNEXIS. Average target price of $36.33

SCYNEXIS Share Price Target

Get share price movements and forecasts by analysts on SCYNEXIS.

What analysts predicted

85.99%UPSIDE

Target Price

$36.33

Current Price

$5.09

Analyzed by

10 Analysts

Target

$36.33

SCYNEXIS target price $36.33, a slight upside of 85.99% compared to current price of $5.09. According to 10 analysts rating.

Indian Investors' Interest in SCYNEXIS Stock

Search interest for SCYNEXIS Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-47% versus previous 30 day period

SCYNEXIS Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
0
0
0
0
1
0
18
-
0
Gross Profit
1
0
0
0
0
1
0
18
-
0
Operating Income
-9
-9
-10
-8
-8
-9
-8
10
-16
-7
EBITDA
1
-13
-2
-3
-4
-6
-8
12
-21
7
Interest Expense
0
0
0
0
0
-
-
-
-
-
Depreciation
-
0
0
0
0
-
-
-
-
-
Income Before Tax
0
-14
-3
-4
-5
-6
-8
12
-21
7
Income Tax Expense
0
-
0
0
-
-
-
-
-
-
Net Income
0
-14
-2
-4
-5
-6
-8
12
-21
7
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
0.00%
100.00%

SCYNEXIS Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
-
13
5
140
3
20
Gross Profit
0
0
0
0
12
4
124
3
20
Operating Income
-26
-29
-48
-51
-60
-85
72
-37
-16
EBITDA
-23
-17
-51
-55
-32
-59
70
-18
-8
Interest Expense
1
2
2
1
3
6
6
2
0
Depreciation
0
0
0
0
0
0
0
1
0
Income Before Tax
-25
-19
-53
-58
-35
-67
67
-21
-8
Income Tax Expense
-
-6
-
-3
-3
-4
0
0
-
Net Income
-25
-12
-53
-55
-32
-62
67
-21
-8
Net Profit Margin
100.00%
100.00%
100.00%
0.00%
97.63%
87.66%
88.85%
100.00%
100.00%

SCYNEXIS Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
-14
-2
-4
-5
-6
-8
12
-21
7
Operating Cash Flow
-4
-10
0
-9
-7
-7
-8
18
-8
-14
Investing Cash Flow
5
1
1
-2
12
11
12
-11
0
-24
Financing Cash Flow
0
-
0
0
-14
-
0
0
24
13
Change in Cash
1
-9
2
-12
-9
3
3
6
15
-26

SCYNEXIS Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-25
-12
-53
-55
-32
-62
67
-21
-8
Operating Cash Flow
-24
-28
-38
-49
-54
-79
60
-24
-5
Investing Cash Flow
-9
0
26
6
-1
-27
-34
6
24
Financing Cash Flow
9
29
42
94
67
48
-36
0
-14
Change in Cash
-24
0
30
51
11
-58
-11
-17
4

Global Institutional Holdings in SCYNEXIS

Check out the Institutions with significant holdings in SCYNEXIS.

Funds
Holdings
VANGUARD INDEX FUNDS
15.72%
Vanguard
4.22%
Michael Rockefeller
3.89%
Fidelity Concord Street Trust
3.68%
Bridgeway
0.16%
See all

SCYNEXIS News & Key Events

  • img

    Today's Timeline - 28 September

    Mon, 05:15 PM

    -

    SCYNEXIS awarded BARDA contract for up to $214M to support SCY-247 antifungal development, maintaining cash runway into 2029.

    Mon, 10:55 PM

    -

    Brookline analyst reiterates Buy rating on SCYNEXIS, citing BARDA funding as a significant positive for SCY-247's development.

    Tue, 02:46 AM

    -

    SCYNEXIS secures BARDA funding for SCY-247, enhancing pipeline without impacting cash runway, with a Buy rating and $32 target.

Insights on SCYNEXIS

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -21.29M → 7.39M (in $), with an average increase of 387.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SCYX stock has moved up by 22.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 72.7% return, outperforming this stock by 88.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 73.7% return, outperforming this stock by 142.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 18.64M → 235.0K (in $), with an average decrease of 98.7% per quarter

About SCYNEXIS

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
OrganisationSCYNEXIS
Headquarters1 Evertrust Plaza, Jersey City, NJ, 07302-6548, US
IndustryMedical - Pharmaceuticals
CEODavid Angulo

Key Management of SCYNEXIS

Name

Title

Dr. David Gonzalez Angulo M.D.

CEO, President & Director

Mr. Scott Sukenick J.D.

Chief Legal Officer & Corporate Secretary

Ms. Daniella Gigante

Vice President of Human Resources & Information Technology

FAQs

What is SCYNEXIS share price today?

SCYNEXIS share price today is $5.09 as on at the close of the market. SCYNEXIS share today touched a day high of $5.51 and a low of $5.10.

What is the 52 week high and 52 week low for SCYNEXIS share?

SCYNEXIS share touched a 52 week high of $9.12 on and a 52 week low of $3.53 on . SCYNEXIS stock price today i.e. is closed at $5.09,which is 44.19% down from its 52 week high and 44.19% up from its 52 week low.

What is SCYNEXIS's market capitalisation today?

SCYNEXIS market capitalisation is $0.00T as on .

How to invest in SCYNEXIS Stock (SCYX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for SCYNEXIS on INDmoney app. Click on Buy button.

What is the minimum amount required to buy SCYNEXIS Stock (SCYX) from India?

Indian investors can start investing in SCYNEXIS (SCYX) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in SCYNEXIS stock (as per the Rupee-Dollar exchange rate as on ). Based on SCYNEXIS share’s latest price of $5.09 as on October 3, 2026 at 1:29 am IST, you will get 1.9646 shares of SCYNEXIS. Learn more about fractional shares .

What are the returns that SCYNEXIS has given to Indian investors in the last 5 years?

SCYNEXIS stock has given -87.02% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?